TARGET FOR IQ · CURRENT AFFAIRS
ICGEB and India’s Biotechnology Cooperation: Trieste Visit, BioE3 and Research Training
Current affairs reading · 3 min read · English
On this page
What is the update?
A November 2026 visit to ICGEB’s Trieste component highlighted India’s cooperation in biotechnology research, scientific training and technology development. The discussion linked international laboratories with work in health, agriculture, industrial biotechnology and environmental applications.
Know the organisation
| Point | Detail |
|---|---|
| Full name | International Centre for Genetic Engineering and Biotechnology |
| Nature | International inter-governmental research organisation |
| Components | Trieste in Italy, New Delhi in India and Cape Town in South Africa |
| Indian supporting department | Department of Biotechnology |
| Main functions | Research, higher education, scientific training and technology transfer |
Science and Technology Minister Jitendra Singh visited the Trieste component and met its leadership and Indian researchers. The organisation’s components are parts of an international research network; they should not be confused with separate national biotechnology regulators.
Facilities examined during the visit
- Biopharmaceutical production and training facilities within the Biotechnology Development Unit.
- A new Biosafety Level 3 laboratory.
- A high-throughput screening facility associated with functional cell biology.
High-throughput screening enables researchers to examine many candidates or conditions systematically. A biosafety designation concerns containment arrangements for laboratory work. Neither the existence of a laboratory nor a ministerial visit establishes that a particular drug, vaccine or crop has obtained regulatory approval.
Research areas connected with India
Areas showcased in the account included biobased chemicals and enzymes, climate-resilient agriculture, carbon capture and utilisation, precision biotherapeutics, and marine and space biomanufacturing. They were discussed as relevant to India’s BioE3 policy.
Specific initiatives included a microbial-biomanufacturing biofoundry, enzyme and yeast systems for ethanol production, biological carbon capture, genome-edited crops and monoclonal-antibody research against infectious diseases. The New Delhi component also works in molecular medicine, vaccines, diagnostics, plant biotechnology, bioenergy and genome-editing technologies. These are research areas, not a list of treatments recommended for public use.
Training and international exchange
Between 2023 and 2026, 67 researchers from 22 countries undertook or began training at ICGEB New Delhi. Workshops and exchanges covered AI in biology, drug development, genome editing, carbon capture, microscopy and flow cytometry.
Training is an important part of scientific cooperation because equipment alone does not create research capability. Researchers need methods, supervision, safety procedures and opportunities to use and share knowledge. Collaboration with developing and emerging economies in Asia and Africa was part of the wider institutional role described.
From research to application
Technology transfer concerns moving a usable research result towards an organisation capable of developing or applying it. Translation can involve further experiments, scaling, intellectual-property arrangements and regulatory requirements, depending on the product. Therefore, research progress and a commercially available product should be recorded as different stages.
For examinations, link this news with science diplomacy, human-resource development and biotechnology’s cross-sector uses. The strongest institutional recall point is the three-component network: Trieste, New Delhi and Cape Town.
Exam revision
- ICGEB is an inter-governmental biotechnology research organisation.
- Components: Trieste, New Delhi and Cape Town.
- DBT supports activities at the New Delhi component.
- 67 researchers from 22 countries trained or began training in New Delhi during 2023–2026.
- Research programmes are not automatically approved commercial products.
Quick questions
Is ICGEB only a medical research institution?
No. Its work also includes plant biotechnology, industrial processes, bioenergy and environmental applications.
What is the relevance of technology transfer?
It connects research outcomes with further development and practical application, subject to the steps required for the technology concerned.
Official references: Ministry of Science & Technology — 2026-11-16.